WHO Classification of Tumours Editorial Board. Digestive system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019. Available from: http://publication.iarc.fr/579.

Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.

Article  PubMed  PubMed Central  Google Scholar 

Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, et al. Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis. 2011;31:49–60.

Article  PubMed  Google Scholar 

Vogel A, Bridgewater J, Edeline J, Kelley RK, Klümpen HJ, Malka D, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆. Ann Oncol. 2023;34:127–40.

Article  PubMed  CAS  Google Scholar 

Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261–80.

Article  PubMed  Google Scholar 

Nakanuma Y, Kakuda Y. Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol. 2015;29:277–93.

Article  PubMed  Google Scholar 

Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol. 2010;2:419–27.

Article  PubMed  PubMed Central  Google Scholar 

Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013;11:13–21.e1; quiz e3–4.

Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512–22.

Article  PubMed  PubMed Central  Google Scholar 

Buettner S, van Vugt JL, IJzermans JN, Groot Koerkamp B. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 2017;10:1131–42.

Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.

Article  PubMed  PubMed Central  Google Scholar 

Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist. 2016;21:594–9.

Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19–31.

Article  PubMed  Google Scholar 

Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, et al. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology. 2019;69:1803–15.

Article  PubMed  Google Scholar 

Bagante F, Spolverato G, Cucchetti A, Gani F, Popescu I, Ruzzenente A, et al. Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: a regret-based decision curves analysis. Surgery (United States). 2016;160:106–17.

Google Scholar 

Groot Koerkamp B, Fong Y. Outcomes in biliary malignancy. J Surg Oncol. 2014;110:585–91.

Article  PubMed  Google Scholar 

Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:364–77.

Luchini C, Parcesepe P, Nottegar A, Parolini C, Mafficini A, Remo A, et al. CD71 in gestational pathology: a versatile immunohistochemical marker with new possible applications. Appl Immunohistochem Mol Morphol. 2016;24:215–20.

Article  PubMed  CAS  Google Scholar 

Lawlor RT, Daprà V, Girolami I, Pea A, Pilati C, Nottegar A, et al. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas. Virchows Arch. 2019;474:105–9.

Article  PubMed  CAS  Google Scholar 

Mattiolo P, Hong S-M, Paolino G, Rusev BC, Marchegiani G, Salvia R, et al. CD117 is a specific marker of intraductal papillary mucinous neoplasms (IPMN) of the pancreas, oncocytic subtype. Int J Mol Sci. 2020;21:E5794.

Article  Google Scholar 

Mafficini A, Simbolo M, Shibata T, Hong S-M, Pea A, Brosens LA, et al. Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma. Mod Pathol. 2022;35:1929–43.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Simbolo M, Bersani S, Vicentini C, Taormina SV, Ciaparrone C, Bagante F, et al. Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles. Expert Opin Ther Targets. 2021;25:1095–105.

Article  PubMed  CAS  Google Scholar 

Sabbatino F, Villani V, Yearley JH, Deshpande V, Cai L, Konstantinidis IT, et al. PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma. Clin Cancer Res. 2016;22:470–8.

Article  PubMed  CAS  Google Scholar 

Luchini C, Cros J, Pea A, Pilati C, Veronese N, Rusev B, et al. PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications. Hum Pathol. 2018;81:157–65.

Article  PubMed  CAS  Google Scholar 

Mafficini A, Lawlor RT, Ghimenton C, Antonello D, Cantù C, Paolino G, et al. Solid pseudopapillary neoplasm of the pancreas and abdominal desmoid tumor in a patient carrying two different BRCA2 germline mutations: new horizons from tumor molecular profiling. Genes. 2021;12:481.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lawlor RT, Mafficini A, Sciammarella C, Cantù C, Rusev BC, Piredda ML, et al. Genomic characterization of hepatoid tumors: context matters. Hum Pathol. 2021;118:30–41.

Article  PubMed  CAS  Google Scholar 

Simbolo M, Silvestris N, Malleo G, Mafficini A, Maggino L, Cocomazzi A, et al. Clinical and genomic characterization of pancreatic ductal adenocarcinoma with signet-ring/poorly cohesive cells. Mod Pathol. 2023;36: 100251.

Article  PubMed  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–23.

Article  PubMed  PubMed Central  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-34.

Article  PubMed  Google Scholar 

Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. New York: Springer; 2002 [cited 2024 Mar 1]. Available from: http://link.springer.com/10.1007/978-1-4757-3656-4.

Edge S, Byrd DR, Compton CC, Fritz AJ, Greene F, Trotti A. AJCC cancer staging manual. 7th ed. Springer International Publishing; 2010.

Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. 8th ed. Springer International Publishing; 2019 [cited 2020 Oct 31]. Available from: https://www.springer.com/gp/book/9783319406176.

Horie H, Akamizu H, Nishimura Y, Maeda N, Kawasaki H, Kimura O, et al. Intrahepatic cholangiocarcinoma with a long-term survival of 12 years after surgical resection: report of a case and review of the literature. Hepatogastroenterology. 1995 [cited 2024 Mar 4];42. Available from: https://pubmed.ncbi.nlm.nih.gov/8751206/.

Shimahara Y, Fujii K, Konishi Y, Yamamoto Y, Honda G, Imuro Y, et al. Nine-year survivor after resection of cholangiocellular carcinoma with tumor thrombi in the main portal trunk. J Gastroenterol. 1998 [cited 2024 Mar 4];33. Available from: https://pubmed.ncbi.nlm.nih.gov/9773946/.

Nozaki Y, Yamamoto M, Ikai I, Yamamoto Y, Ozaki N, Fujii H, et al. Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer. 1998;83:1923–9.

Article  PubMed  CAS  Google Scholar 

Saiura A, Takayama T, Sano K, Toyoda H, Abe H, Kubota K, et al. Metachronous bile duct cancer in a patient surviving for a decade and undergoing curative surgery twice. Jpn J Clin Oncol. 1999;29:353–5.

Article  PubMed  CAS  Google Scholar 

Murakami Y, Yokoyama T, Takesue Y, Hiyama E, Yokoyama Y, Kanehiro T, et al. Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes. Surgery. 2000;127:105–6.

Article  PubMed  CAS  Google Scholar 

Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, et al. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg. 2002;26:687–93.

Article  PubMed  Google Scholar 

Yamamoto M, Takasaki K, Imaizumi T, Ariizumi S, Matsumura N, Nakano M. A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report. Jpn J Clin Oncol. 2002 [cited 2024 Mar 4];32. Available from: https://pubmed.ncbi.nlm.nih.gov/12110637/.

Kurosaki I, Hatakeyama K. Repeated hepatectomy for recurrent intrahepatic cholangiocarcinoma: report of two cases. Eur J Gastroenterol Hepatol. 2005;17:125.

Article